EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives

Anne Aries iD, Bernard Drénou iD, Rachid Lahlil iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157547 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anne Aries und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recherche en Hématologie et Transplantation (IRHT), Hôpital du Hasenrain, 87 Avenue d'Altkirch, 68100 Mulhouse, France. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Central Nervous System Neoplasms, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Le Fonds Européen de Développement Régional (FEDER), Région Grand Est, Mulhouse Alsace Agglomération and Fondation Lalance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To deliver the most effective cancer treatment, clinicians require rapid and accurate diagnoses that delineate tumor type, stage, and prognosis. Consequently, minimizing the need for repetitive and invasive procedures like biopsies and myelograms, along with their associated risks, is a critical challenge. Non-invasive monitoring offers a promising avenue for tumor detection, screening, and prognostication. While the identification of oncogenes and biomarkers from circulating tumor cells or tissue biopsies is currently standard practice for cancer diagnosis and classification, accumulating evidence underscores the significant role of epigenetics in regulating stem cell fate, including proliferation, self-renewal, and malignant transformation. This highlights the importance of analyzing the methylome, exosomes, and circulating RNA for detecting cellular transformation. The development of diagnostic assays that integrate liquid biopsies with epigenetic analysis holds immense potential for revolutionizing tumor management by enabling rapid, non-invasive diagnosis, real-time monitoring, and personalized treatment decisions. This review covers current studies exploring the use of epigenetic regulation, specifically the methylome and circulating RNA, as diagnostic tools derived from liquid biopsies. This approach shows promise in facilitating the differentiation between primary central nervous system lymphoma and other central nervous system tumors and may enable the detection and monitoring of acute myeloid/lymphoid leukemia. We also discuss the current limitations hindering the rapid clinical translation of these technologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticCentral Nervous System NeoplasmsLeukemia, Myeloid, AcuteHumansLiquid BiopsyBiomarkers, TumorDNA Methylation

Stichwörter der Autor:innen

PCNSLcirculating RNAearly diagnosisepigeneticleukemialiquid biopsylymphomamethylome

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Institut de Recherche en Hématologie et Transplantation (IRHT), Hôpital du Hasenrain, 87 Avenue d'Altkirch, 68100 Mulhouse, France.
  • Laboratoire d'Hématologie, Groupe Hospitalier de la Région de Mulhouse Sud-Alsace, Hôpital E. Muller, 20 Avenue de Dr. Laennec, 68100 Mulhouse, France.

ORCID-Profile: Anne Aries, Bernard Drénou, Rachid Lahlil

Förderung

  • Le Fonds Européen de Développement Régional (FEDER)
  • Région Grand Est, Mulhouse Alsace Agglomération and Fondation Lalance

Zitieren

APA

Aries, A., Drénou, B., & Lahlil, R. (2025). Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157547

Vancouver

Aries A, Drénou B, Lahlil R. Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157547

BibTeX
@article{Aries2025,
  author = {Aries, Anne and Drénou, Bernard and Lahlil, Rachid},
  title = {Liquid Biopsy and Epigenetic Signatures in AML, ALL, and CNS Tumors: Diagnostic and Monitoring Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157547}
}
Kostenlos starten →